Cactus Life Sciences’ Top 5 Trends of 2024: Insights Driving Tomorrow’s MedComms
Here, we revisit our most thought-provoking articles and whitepapers, each addressing pivotal trends that influence the ever-evolving biopharma landscape...
Read MoreTop Stories
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
It’s Never Too Soon: How and When to
Engagement with Medical Affairs is critical at every...
Leveraging Social Media to Transform Medical
This whitepaper explores the role of social media in...
Filter
The Business Case for Diversity, Equity, and Inclusion (DE&I) in the Pharma Industry
To learn how much businesses can gain from more diverse and inclusive workplaces and why...
Why Do Plain Language Clinical Trial Summaries Matter?
Did you know that the European Medicines Agency’s Clinical Trials Regulation comes into effect on...
Beyond Words: How Voice, Graphics, and Video Are Changing the Way Researchers Reach Audiences
The growth and adoption of the internet and mobile technology have provided publishers and authors...
Promoting Diversity and Inclusion in Clinical Trials – New England Journal of Medicine’s New Policy
Read this update on how the New England Journal of Medicine is trying to promote...
3 Interesting Facts about Plain Language Summaries
Did you know these 3 facts about plain language summaries?...
Clinical Trial Summaries – What Are They and Why Do They Matter for Pharma?
A majority of patients feel lay summaries for clinical trials are very important and won’t...